Longitudinal SARS-CoV-2 wastewater genomic surveillance in Surat, India: comparison with clinical genomes and detection of recurrent environmental mutations
Background Environmental genomic surveillance is a vital One Health tool for tracking pathogen circulation and preparing for emerging infectious diseases. While the COVID-19 pandemic accelerated wastewater genomic surveillance globally, its broader role as an early-warning framework for new pathogens remains only partly understood. Methods We conducted a longitudinal wastewater genomic surveillance study in Surat, India, under INSACOG. Between March 2023 and January 2024, 945 samples were screened, yielding 51 wastewater consensus sequences meeting predefined quality criteria, compared with 1,814 regional human genomes. Analyses assessed lineage dynamics, mutation sharing, lead times, persistence, and cryptic genomic signatures. Results Comparative analysis identified 953 mutations shared between wastewater and clinical genomes and 205 mutations not observed in the selected clinical dataset. Fifteen mutations were detected in wastewater before their first observation in the analyzed clinical sequence dataset, with apparent lead times ranging from 21 to 187 days. The spike mutation S:I670V preceded first observation in the clinical dataset by 187 days. Longitudinal analysis further identified nine recurrently co-detected mutations that remained detectable for approximately 147 days across multiple independent wastewater genomes; genomic linkage among these mutations has not yet been established from consensus sequence data alone. Conclusions Our findings show that integrated environmental and clinical genomic surveillance identified mutation signals earlier in wastewater than in the available local clinical sequence collection, and revealed recurrently co-detected mutations underrepresented in clinical samples. Although demonstrated using SARS-CoV-2 only, this approach may be adaptable to other pathogens with further validation, and environmental genomic surveillance could serve as one component of a broader One Health preparedness strategy.
Authors
- Urvisha Beladiya (ORCID: https://orcid.org/0000-0002-3743-2611)
- Vishal Arvindlal Mevada (ORCID: https://orcid.org/0000-0003-0739-026X)
- Rajesh Kanjibhai Patel (ORCID: https://orcid.org/0000-0002-4712-1921)
- Madhvi N. Joshi (ORCID: https://orcid.org/0000-0003-4102-7114)
- Pravin R. Dudhagara (ORCID: https://orcid.org/0000-0002-4041-6751)
- Ramesh J. Pandit (ORCID: https://orcid.org/0000-0002-0382-7236)
- S Sreekutti (ORCID: https://orcid.org/0009-0005-1196-5013)
- Paheli Sharma
- Henisha Pandulkar
- Jigna Desai
- Ashka Vansia
- Ankit Beladiya
Institutions
- Veer Narmad South Gujarat University (IN)
- National Forensic Sciences University (IN)
- Sardar Vallabhbhai National Institute of Technology Surat (IN)
- Gujarat Biotechnology Research Centre (IN)
Publication Details
- Journal
- Frontiers in Tropical Diseases
- Published
- 2026-11-17
- DOI
- https://doi.org/10.3389/fitd.2026.1930646
- Primary Topic
- SARS-CoV-2 detection and testing
- Type
- article
- Field-Weighted Citation Impact
- 0.00